Keratosis follicularis spinulosa decalvans
| Keratosis follicularis spinulosa decalvans | |
|---|---|
| Synonyms | KFSD |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Follicular hyperkeratosis, alopecia, photophobia, corneal dystrophy |
| Complications | Scarring alopecia, visual impairment |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Clinical diagnosis, genetic testing |
| Differential diagnosis | Ichthyosis, atopic dermatitis, lichen planopilaris |
| Prevention | N/A |
| Treatment | Emollients, keratolytics, retinoids, topical corticosteroids |
| Medication | N/A |
| Prognosis | Variable, often progressive |
| Frequency | Rare |
| Deaths | N/A |
Keratosis Follicularis Spinulosa Decalvans (KFSD) is a rare, X-linked, genodermatosis disorder characterized by keratotic follicular papules, progressive cicatricial alopecia, and associated with eye symptoms. It was first described by Macleod in 1909.
Symptoms and Signs[edit]
KFSD is characterized by the presence of keratotic follicular papules, progressive cicatricial alopecia, and occasionally associated with photophobia, corneal dystrophy, and other ocular abnormalities. The onset of the disease usually occurs in infancy or early childhood, but late-onset forms of the disease have also been reported.
Causes[edit]
KFSD is a genetic disorder that is inherited in an X-linked recessive manner. The exact genetic mutation that causes KFSD is currently unknown, but it is believed to involve a defect in the keratinization process of the hair follicle.
Diagnosis[edit]
The diagnosis of KFSD is primarily based on clinical findings. A skin biopsy may be performed to confirm the diagnosis. Genetic testing may also be useful in confirming the diagnosis and for genetic counseling purposes.
Treatment[edit]
There is currently no cure for KFSD. Treatment is symptomatic and may include topical keratolytics, retinoids, and emollients. In severe cases, systemic retinoids may be used. Regular follow-up with an ophthalmologist is recommended for those with ocular involvement.
Prognosis[edit]
The prognosis of KFSD is variable. Some individuals may have mild symptoms and a relatively normal life expectancy, while others may experience severe symptoms and complications such as progressive hair loss and vision loss.
See Also[edit]
References[edit]
<references />
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


